Wednesday, October 30, 2019 at 8:30 a.m. EDT to discuss its third quarter 2019 financial results and operational developments.
PARSIPPANY, N.J.--(BUSINESS WIRE)-- The Medicines Company (NASDAQ: MDCO) will host a conference call and audio webcast on Wednesday, October 30, 2019 at 8:30 a.m. EDT to discuss its third quarter 2019 financial results and operational developments.
The conference call may be accessed by telephone as follows:
| U.S./Canada: | (877) 407-0312 | ||
| International: | (201) 389-0899 | ||
| Conference ID: | 13696004 |
A live audio webcast of the conference call may be accessed in the Investors section of The Medicines Company website.
A taped replay of the conference call will be available after the call concludes, and may be accessed by telephone as follows:
| U.S./Canada: | (877) 660-6853 | ||
| International: | (201) 612-7415 | ||
| Conference ID: | 13696004 |
An archived webcast will be also be available after the call concludes.
About The Medicines Company
The Medicines Company (NASDAQ: MDCO) is a biopharmaceutical company with a singular, relentless focus on addressing the greatest global healthcare challenge and burden today – cardiovascular disease. Our purpose is to halt the deadly progression of atherosclerosis and the cardiovascular risk created by high levels of LDL cholesterol. The Company is headquartered in Parsippany, New Jersey. For more information, please visit www.themedicinescompany.com and follow us on Twitter @MDCONews and LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191024005693/en/
Contacts
Investor Relations
Krishna Gorti, M.D.
Vice President, Investor Relations
973 290 6122
krishna.gorti@themedco.com
Media Inquiries
Michael Blash
Vice President, Communications
973 290 6100
michael.blash@themedco.com
Source: The Medicines Company
View this news release online at:
http://www.businesswire.com/news/home/20191024005693/en
